Documents

A list of downloadable documents created during development.

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): final appraisal determination

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): update on scheduling

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): appraisal consultation

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): EIA form (guidance development)

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): EIA form

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): final scope

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): final matrix

Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy): comments on the draft scope

Prostate cancer (meta castration resistant) - abiraterone: appendix B - draft scope for consultation (pre-referral) January 2011

Prostate cancer (meta castration resistant) - abiraterone: appendix C - provisional matrix (pre-referral) January 2011